Marshall Wace’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Marshall Wace’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-113,073	Closed	-$3.11M	–	3641
2021 Q2	$3.11M	Buy	+113,073	New	+$2.22M	0.01%	1126
2021 Q1	–	Sell	-35,485	Closed	-$654K	–	3036
2020 Q4	$654K	Sell	35,485 -139,721	-80%	-$2.5M	﹤0.01%	1371
2020 Q3	$2.38M	Buy	+175,206	New	+$2.7M	0.02%	761

Marshall Wace's TBIO Position: Q3 2021 in Review

Marshall Wace sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 113,073 shares — an estimated $3.11M sold.

Marshall Wace first reported a position in TBIO in Q3 2020 and held it in 3 quarters. The position peaked at $3.11M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Marshall Wace reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Marshall Wace sold 113,073 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $3.11M.
Marshall Wace first reported a position in Translate Bio, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
Marshall Wace's Translate Bio, Inc. Common Stock position peaked at $3.11M in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.